Clinical Trials

NCT04758650 | TERMINATED | PHASE2
29 participants

Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2021-01-26
Completion:
2025-01-08
Conditions
  • Solid Malignancy Located in the Head and Neck
  • Cancer
  • Carotid Stenosis
  • Atherosclerosis of Artery
  • Hodgkin Lymphoma, Adult
  • Non Hodgkin Lymphoma
  • HLH
  • Cardiac Sarcoidosis
  • Sarcoidosis
Interventions
  • DRUG
No Results Yet
NCT04692818 | RECRUITING | NA
125 participants

3D Ultrasound Breast Imaging

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2021-11-10
Completion:
2026-12-31
Conditions
  • Breast Tumor
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT04646226 | ACTIVE_NOT_RECRUITING | NA
103 participants

The Arteriovenous Vascular (AV) ACCESS Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2022-08-18
Completion:
2027-06-30
Conditions
  • End-Stage Kidney Disease
  • Hemodialysis Complication
Interventions
  • DEVICE
  • PROCEDURE
No Results Yet
NCT04573920 | ACTIVE_NOT_RECRUITING | PHASE2
103 participants

Atrasentan in Patients With Proteinuric Glomerular Diseases

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2021-03-15
Completion:
2024-07-02
Conditions
  • IgA Nephropathy
  • Focal Segmental Glomerulosclerosis
  • Alport Syndrome
  • Diabetic Kidney Disease
  • Diabetic Nephropathy Type 2
  • Immunoglobulin A Nephropathy
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page